| ADMET | absorption, distribution, metabolism, excretion, and toxicity |
| AI | artificial intelligence |
| ATOM | Accelerating Therapeutics for Opportunities in Medicine |
| CBVLS | compound-based virtual ligand screening |
| CDISC | Clinical Data Interchange Standards Consortium |
| CRDC | Cancer Research Data Commons |
| CTD | Common Technical Document |
| DL | deep learning |
| EBI | European Bioinformatics Institute |
| EHR | electronic health records |
| EMA | European Medicines Agency |
| EMBL | European Molecular Biology Laboratory |
| EU | European Union |
| FAIR | Findable, Accessible, Interoperable, and Reusable |
| FDA | Food and Drug Administration |
| FHIR | Fast Healthcare Interoperability Resources |
| GDC | Genomic Data Commons |
| GDPR | General Data Protection Regulation |
| HCS | high content screening |
| HIPAA | Health Insurance Portability and Accountability Act |
| HTS | High-Throughput Screening |
| ICH | International Council of Harmonisation |
| InChI | International Chemical Identifier |
| LLM | large language model |
| MCTS | Monte Carlo tree search |
| MIDD | Model-Informed Drug Development |
| MLPCN | Molecular Library Probe Production Centers Network |
| ML | machine learning |
| NCI | National Cancer Institute |
| NDA | New Drug Application |
| NIH | National Institutes of Health |
| OMOP | Observational Medical Outcomes Partnership |
| PDB | Protein Data Bank |
| PHI | protected health information |
| QSAR | quantitative structure–activity relationships |
| RBVLS | receptor-based virtual ligand screening |
| RECIST | Response Evaluation Criteria in Solid Tumors |
| RTOR | Real-Time Oncology Review |
| RWD | real-world data |
| RWE | real-world evidence |
| SMILES | Simplified Molecular Input Line Entry System |
| TCGA | The Cancer Genome Atlas |
| US | United States |
| USD | United States dollar |
| VA | U.S. Department of Veterans Affairs |
| VLS | virtual ligand screening |